Travel stocks continue ascent as London markets post mixed open February 10, 2022 Travel stocks continued their ascent today in a positive day for London markets. The capital’s premier FTSE 100 index closed 0.38 per cent higher at 7,672.40 points, while the domestically-focused FTSE 250 index, which is more aligned with the health of the UK economy, added 0.11 per cent to finish at 22,207.75 points. Airline stocks [...]
Unilever rules out any major acquisitions this year after failed £50bn GlaxoSmithKline deal February 10, 2022 Unilever said this morning the consumer giant saw a 4.5 per cent jump in sales for the past year as it was boosted by higher prices. The company, which makes products ranging from Marmite to Ben & Jerrys ice cream, said this was its fastest growth in nine years, driven by a 2.9 per cent [...]
GlaxoSmithKline revels in £8.8bn profit ahead of consumer healthcare demerger February 9, 2022 GlaxoSmithKline (GSK) has reported full-year sales of £34bn, boosted by strong pharmaceutical sales over the past 12 months.
Shareholders circle as Unilever braces for full year results February 6, 2022 Top shareholders are piling pressure on Unilever over its failed takeover bid for Glaxosmithkline (GSK) ahead of the company's annual results.
Unilever should ‘seriously think about splitting’, says major shareholder February 5, 2022 One of Unilever’s largest investors has called for the consumer goods giant to split, following its failed GlaxoSmithKline (GSK) bid. Bert Flossbach, founder and chief investment officer of Flossbach von Storch, one of Unilever’s top 10 shareholders, said that the Marmite-to-Dove soap maker is too diverse, and would benefit from slimming its operations. “Unilever should [...]
Investor engagement surges as shareholders hold bosses to account on ESG and pay February 2, 2022 Shareholder engagement has skyrocketed in the past year as investors piled into annual general meetings (AGMs) to hold bosses to account on issues like ESG and executive pay, new data has revealed.
GSK set to gain $1.25bn in HIV patent settlement with Gilead February 2, 2022 GSK is set to benefit from a whopping $1.25bn payment as part of a settlement between drug maker Gilead and its HIV department.
The charge of the activist investors February 1, 2022 Analyst investors have been on the charge in the UK, Charlie Conchie asks why.
Editorial: The activists are a welcome sign of faith in the City’s future January 31, 2022 The City is not always portrayed well in the wider media, but a certain kind of Square Mile institution was rather effectively deployed at the beginning of Monty Python’s The Meaning of Life. The Crimson Permanent Assurance, a “once proud family firm fallen on hard times,” fights back against its new ownership by the Very [...]
Vodafone feels the pressure after activist investor Cevian builds a stake January 31, 2022 Voadafone is expected to speed up an organisational overhaul after it was revealed that a notorious activist investor had taken a stake in the firm.